peginterferon lambda-1a: Clinical Trials

3 trials of peginterferon lambda-1a, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3

Follow peginterferon lambda-1a: new trials by email Literature Review of peginterferon lambda-1a trials Research Report on peginterferon lambda-1a

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Study of Safety, Pharmacokinetics, Pharmacodynamics of Peglamda (Peginterferon Lamda 1) on Healthy Volunteers and the Preliminary Evaluation of Peglamda and Hepasig (Ribavirin) Treatment's Effects on Chronic Hepatitis C Patients
Peginterferon lambda - Hepatitis C
Phase 1CompletedNanogen Pharmaceutical Biotechnology Joint Stock Company602013-12-012016-12-15
Pharmacokinetic Study of BMS-914143 in Participants With Normal Renal Function and Mild, Moderate, Severe and End-stage Renal Dysfunction
BMS-914143 (Peginterferon Lambda-1a) - Chronic Hepatitis B Virus Infection, Chronic Hepatitis C Virus Infection
Phase 1CompletedBristol-Myers Squibb432012-09-012013-06-05
Study of PEG-rIL-29 (or PEG-IFN Lambda) in Subjects With Chronic Hepatitis C Virus Infection
PEGylated recombinant interleukin 29 (PEG-rIL-29) - Hepatitis C, Chronic
Phase 1CompletedZymoGenetics562007-12-012009-10-07

Conditions studied

Hepatitis C (2)  ·  Hepatitis B, Chronic (1)  ·  Hepatitis C, Chronic (1)  ·  Infections (1)  ·  Virus Diseases (1)

Sponsors

Bristol-Myers Squibb (1)  ·  Nanogen Pharmaceutical Biotechnology Joint Stock Company (1)  ·  ZymoGenetics (1)

Countries

United States (2)  ·  Canada (1)  ·  Vietnam (1)

Top investigators

Diana F Hausman, MD (1)  ·  Dr.Chinh Trong Nguyen, PhD (1)